Wound Therapy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Wound Type (Chronic Wounds, Acute Wounds), By Product (Negative Pressure Wound Therapy (NPWT), Oxygen and Hyperbaric Oxygen Equipment, Electric Stimulation Devices, Pressure Relief Devices, Others), By End-User (Hospitals, Specialty Clinics, Home Healthcare, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 4.96 Billion
CAGR (2026-2031)	5.63%
Fastest Growing Segment	Negative Pressure Wound Therapy (NPWT)
Largest Market	North America
Market Size (2031)	USD 6.89 Billion

Market Overview

The Global Wound Therapy Devices Market will grow from USD 4.96 Billion in 2025 to USD 6.89 Billion by 2031 at a 5.63% CAGR. Wound therapy devices are specialized medical instruments, such as negative pressure systems and hyperbaric chambers, designed to manage and accelerate the healing of acute and chronic injuries. The primary driver supporting market growth is the escalating global prevalence of lifestyle diseases like diabetes and obesity, which significantly increase the incidence of complex ulcers. Additionally, the aging global population sustains demand, as geriatric patients frequently suffer from compromised physiological healing capabilities and pressure injuries.

However, market expansion is significantly impeded by the high acquisition costs associated with advanced therapeutic equipment, which often limits adoption in price-sensitive regions. This economic barrier persists despite the growing patient pool requiring specialized care. According to the International Diabetes Federation, in 2024, approximately 589 million adults globally were living with diabetes, a major contributor to the prevalence of chronic wounds. This statistic underscores the urgent necessity for accessible therapeutic solutions to manage the increasing burden on healthcare systems.

Key Market Drivers

The escalating global prevalence of chronic and lifestyle-related diseases creates a critical foundation for the Global Wound Therapy Devices Market. Conditions such as obesity and diabetes severely compromise physiological healing processes, leading to a higher frequency of hard-to-heal ulcers and chronic skin defects that require advanced intervention. As metabolic disorders become more widespread, the volume of patients requiring long-term wound management solutions expands, necessitating the use of negative pressure wound therapy and bioactive devices to prevent infection and amputation. According to the World Obesity Federation, March 2024, in the 'World Obesity Atlas 2024', more than one billion people worldwide are now living with obesity, a condition directly correlated with increased susceptibility to venous leg ulcers and pressure injuries. This massive patient population drives the continuous need for therapeutic devices capable of addressing complex, non-healing wounds.

Concurrently, the rising incidence of traumatic injuries and burn cases significantly amplifies the demand for effective wound closure and management systems. Severe burns and physical trauma require immediate and prolonged therapeutic support to restore tissue integrity, making specialized devices essential for acute care settings. According to the journal Burns, March 2024, in the study 'Global burden of burns and its association with socio-economic development status', the global prevalence of severe burn injury cases was estimated at 12.99 million, highlighting the substantial burden of acute injuries on healthcare providers. This acute demand translates into tangible market expansion as healthcare systems invest in advanced management products. For instance, according to Smith+Nephew, February 2024, in the 'Fourth Quarter and Full Year 2023 Results', the company's Advanced Wound Management business unit delivered 6.4% underlying revenue growth, reflecting the sustained adoption of these technologies across global markets.

Download Free Sample Report

Key Market Challenges

The high acquisition costs associated with advanced therapeutic equipment present a formidable obstacle to the expansion of the global wound therapy devices market. Many healthcare facilities, especially those in developing regions and publicly funded systems, operate under strict budgetary constraints that limit their ability to invest in expensive technologies such as negative pressure wound therapy systems. Consequently, the adoption of these specialized devices is often restricted to affluent urban centers or private institutions. This financial disparity forces a reliance on traditional, lower-cost alternatives in price-sensitive markets, thereby reducing the potential revenue stream for manufacturers and slowing the overall penetration of advanced solutions.

This economic barrier is particularly limiting when viewed against the backdrop of the substantial patient population requiring effective wound management. According to the Wound, Ostomy, and Continence Nurses Society, in 2024, lower extremity arterial disease was estimated to affect 6.5 million people in the United States. The high prevalence of such conditions indicates a critical need for efficient healing interventions. However, the prohibitive capital expenditure required for advanced devices prevents their widespread utilization for this expanding patient pool, directly hampering the growth trajectory of the market.

Key Market Trends

The adoption of Single-Use and Disposable Negative Pressure Wound Therapy (NPWT) Systems is fundamentally reshaping the market by offering cost-effective, portable alternatives to traditional capital-intensive equipment. Unlike bulky canister-based units, these miniaturized disposable devices enable patients to receive continuous therapy in home care settings, significantly enhancing mobility and reducing hospital lengths of stay. This shift addresses the economic barriers of advanced wound care by eliminating the need for expensive hardware purchases and maintenance. The rapid uptake of these solutions is reflected in the financial performance of key industry players. According to Smith+Nephew, February 2024, in the 'Fourth Quarter and Full Year 2023 Results', the company's Advanced Wound Devices segment achieved double-digit underlying revenue growth, primarily driven by the robust demand for its single-use PICO Negative Pressure Wound Therapy System.

Concurrently, the incorporation of Artificial Intelligence for Automated Wound Assessment is transforming clinical workflows by replacing subjective manual measurements with precise digital analysis. AI-powered platforms now utilize standard smartphone cameras to capture wound imagery, automatically calculating surface area and tissue composition to track healing progress with high accuracy. This technological integration enhances clinical decision-making by standardizing documentation and enabling the early detection of complications, which is critical for managing chronic conditions. The sector is seeing increased capital inflow to support these digital capabilities. According to Swift Medical, January 2024, in the announcement 'Swift Medical Secures $8M to Power AI-Driven Wound Care', the company successfully raised $8 million specifically to accelerate the development of its artificial intelligence platform, which currently supports over 4,000 healthcare facilities.

Segmental Insights

Negative Pressure Wound Therapy constitutes the fastest-growing segment within the global wound therapy devices market. This expansion is driven by the rising prevalence of chronic conditions, such as diabetic ulcers and pressure injuries, which necessitate effective exudate management and accelerated tissue closure. Healthcare providers increasingly favor this modality as it reduces the duration of hospital stays and mitigates infection risks. Furthermore, the market is benefiting from the adoption of portable, single-use systems that facilitate cost-effective home care. Continued clearances by regulatory bodies like the U.S. FDA for these devices further validate their clinical efficacy and support broader utilization.

Regional Insights

North America maintains a leading position in the global wound therapy devices market, primarily due to the rising prevalence of chronic conditions such as diabetes which necessitate ongoing wound management. The region benefits from a well-established healthcare infrastructure and the presence of major industry manufacturers. Market growth is further supported by favorable reimbursement policies from the Centers for Medicare & Medicaid Services, which facilitate patient access to essential treatments. Additionally, the U.S. Food and Drug Administration provides a structured regulatory framework that streamlines product approvals, reinforcing the region's dominance.

Recent Developments

• In July 2024, Mölnlycke Health Care announced a strategic collaboration and a US $15 million investment in MediWound Ltd, a company specializing in enzymatic therapeutics for non-surgical wound debridement. This partnership aims to accelerate the development and commercialization of next-generation solutions that remove dead tissue from wounds, a critical step in preparing the wound bed for healing. The CEO of Mölnlycke Health Care emphasized that this investment aligns with the company's strategy to bring radical innovations to the wound care market and provide improved clinical outcomes and patient experiences globally.
• In April 2024, Smith & Nephew launched a new negative pressure wound therapy (NPWT) system in the United States, specifically designed for home-based care of patients with chronic wounds. The system is lightweight, compact, and features a discreet canister, allowing patients to carry or wear the device comfortably while continuing their daily activities. The Vice President and General Manager of NPWT at Smith & Nephew noted that the patient-centric design aims to reduce the stigma and discomfort often associated with bulky medical devices. The company also secured national distribution partnerships to ensure broader patient access to this therapy.
• In March 2024, Integra LifeSciences Holdings Corporation introduced a dual-syringe system intended to provide access to hard-to-reach areas in complex wound reconstruction cases. This new system enables the precise mixing and delivery of a flowable urinary bladder matrix paste, allowing surgeons to prepare an even wound surface in challenging geometries such as tunneled or undermined wounds. The Vice President of Global Marketing for the Tissue Technologies Product Division highlighted that this innovation was developed in close collaboration with surgeons to solve meaningful treatment problems and set new standards of care in regenerative medicine.
• In January 2024, Coloplast announced the launch of a new silicone foam dressing designed for both pressure injury prevention and wound management in the United States. This product features a unique technology that conforms to the wound bed and the body's contours to reduce gap formation and prevent exudate pooling. The Vice President of Wound & Skin Care for North America at Coloplast stated that the innovation aims to simplify workflows for healthcare providers while delivering a secure and comfortable fit for patients. The launch addresses the growing demand for effective solutions in treating chronic conditions and preventing hospital-acquired pressure injuries.

Key Market Players

• 3M Company
• Cardinal Health, Inc.
• Convatec Group plc
• Smith & Nephew Plc
• Paul Hartmann AG
• Sechrist Industries, Inc.
• Mölnlycke Health Care AB
• Medela AG
• Deroyal Industries, Inc.
• Coloplast A/S

By Wound Type	By Product	By End-User	By Region
Chronic Wounds Acute Wounds	Negative Pressure Wound Therapy (NPWT) Oxygen and Hyperbaric Oxygen Equipment Electric Stimulation Devices Pressure Relief Devices Others	Hospitals Specialty Clinics Home Healthcare Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Wound Therapy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Wound Therapy Devices Market , By Wound Type:

• Chronic Wounds
• Acute Wounds

• Wound Therapy Devices Market , By Product:

• Negative Pressure Wound Therapy (NPWT)
• Oxygen and Hyperbaric Oxygen Equipment
• Electric Stimulation Devices
• Pressure Relief Devices
• Others

• Wound Therapy Devices Market , By End-User:

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

• Wound Therapy Devices Market , By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE